Paxlovid for COVID-19, Ivermectin Ineffective for COVID-19, One Year Outcomes for ICU COVID-19 Patients, Diagnostic Strategies for Ruling Out PE, Thiamine for Alcohol Use Disorder, Skin Color and Pulse Oximetry

Last Week in Medicine

We finally have the published trial results for Paxlovid! We also look at the latest trial showing the ivermectin is ineffective in treating COVID-19 and one year outcomes in ICU COVID-19 patients. We also look at a meta-analysis of trials looking at different diagnostic strategies for ruling out PE, a retrospective study of thiamine use in ICU patients with alcohol use disorder, and a new study on pulse oximetry in people with different skin color. Check it out!
Paxlovid for High Risk, Nonhospitalized Patients with COVID-19
Ivermectin for Mild to Moderate COVID-19
County-Level Prescriptions for Hydroxychloroquine and Ivermectin and Presidential 2020 Voting Patterns

Diagnostic Strategies for Ruling out PE
Thiamine Use in ICU Patients with Alcohol Use Disorder

Racial Disparities in Hypoxemia Detection with Pulse Oximetry
Vitamin D and Mortality
Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R